← Leaderboards
Rowan A Chlebowski
Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center
$2,429,446
Attributed
$2,429,446
Total exposure
13
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $934.4K · FY2008–10$1M$750K$500K$250K$0
'08
'09
'10
Funding mix
By agency
NIH$2,429,446 · 13
By mechanism
M01$2,429,446 · 13
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourceGrantFundingUnited States National Institutes Of HealthInstitutionResearch PersonnelResourcesComputer Retrieval Of Information On Scientific Projects DatabaseRandomizedClinical TrialsWomanVisitUnited StatesPostmenopauseBloodLifeLungParticipantMalignant Breast NeoplasmBaseMalignant Neoplasm Of ProstateBlood SpecimenMalignant NeoplasmsMedical
Grant awards (13)
CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)$486,559
M01 · FY2010 · RR · contact PI
A PHASE III RANDOMIZED STUDY OF EXEMESTANE PLUS PLACEBO VERSUS EXEMESTANE PLU$329,901
M01 · FY2010 · RR · contact PI
THE INFLUENCE OF FIVE YEARS OF EXEMESTANE ON BONE MINERAL DENSITY$104,132
M01 · FY2010 · RR · contact PI
LIFESTYLE INTERVENTION STUDY IN ADJUVANT TREATMENT OF EARLY BREAST CANCER (LISA)$8,294
M01 · FY2010 · RR · contact PI
PREVENTION OF LUNG FUNCTION DECLINE WITH VITAMIN E AND SELENIUM RESPIRATORY ANCI$5,529
M01 · FY2010 · RR · contact PI
CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)$485,142
M01 · FY2009 · RR · contact PI
A PHASE III RANDOMIZED STUDY OF EXEMESTANE PLUS PLACEBO VERSUS EXEMESTANE PLU$295,048
M01 · FY2009 · RR · contact PI
THE INFLUENCE OF FIVE YEARS OF EXEMESTANE ON BONE MINERAL DENSITY$51,190
M01 · FY2009 · RR · contact PI
PREVENTION OF LUNG FUNCTION DECLINE WITH VITAMIN E AND SELENIUM RESPIRATORY ANCI$4,655
M01 · FY2009 · RR · contact PI
LIFESTYLE INTERVENTION STUDY IN ADJUVANT TREATMENT OF EARLY BREAST CANCER (LISA)$1,862
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)$396,181
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: A PHASE III RANDOMIZED STUDY OF EXEMESTANE PLUS PLACEBO VERSUS E$179,816
M01 · FY2008 · RR · contact PI
RESPIRATORY ANCILLARY STUDY (RAS) AS A SUBSTUDY OF SELECT TRIAL$81,137
M01 · FY2008 · RR · contact PI